HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin.

AbstractOBJECTIVE:
To compare the effects of botulinum toxin on static and dynamic aspects of eye movements, and thereby elucidate the mechanisms of its action on eye muscles.
BACKGROUND:
Laboratory evidence indicates that static alignment and saccades are subserved by different extraocular muscle fiber types, and botulinum toxin may cause specific dysfunction of the fibers controlling static alignment. Diplopia is a well-known side effect of periorbital botulinum toxin injections in humans, and may be a clinical correlate of the laboratory findings.
METHODS:
Search coil recording of eye movements was performed in one patient with systemic botulism, and in three patients with diplopia following periorbital injection of botulinum toxin A.
RESULTS:
In the patient with acute botulism, eye movement alignment, range, and saccadic velocity profiles were abnormal. In three patients with iatrogenic diplopia, static alignment was abnormal but movement range and saccadic velocities were within normal limits. Edrophonium improved the range of movements and saccadic velocities in the patient with systemic botulism but was ineffective in reversing ocular misalignment in the one iatrogenic patient to whom it was administered.
CONCLUSIONS:
Precise alignment is subserved by orbital singly innervated muscle fibers, and the effects of botulinum toxin are greatest on these fibers. This predilection is apparent when the toxin dose is very small, as must have been the case in our patients with iatrogenic diplopia. The lack of a response to edrophonium probably reflects structural damage to muscle fibers. In contrast, larger doses of toxin produce an acute dysfunction of all extraocular muscle fiber types, which is responsive to edrophonium and consequently reflects partial blockade at the neuromuscular junction.
AuthorsJ S Stahl, L Averbuch-Heller, B F Remler, R J Leigh
JournalNeurology (Neurology) Vol. 51 Issue 4 Pg. 1093-9 (Oct 1998) ISSN: 0028-3878 [Print] United States
PMID9781535 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Dyskinesia Agents
  • Parasympathomimetics
  • Edrophonium
  • Botulinum Toxins
Topics
  • Adult
  • Aged
  • Anti-Dyskinesia Agents (adverse effects, metabolism)
  • Botulinum Toxins (adverse effects, metabolism)
  • Botulism (physiopathology)
  • Diplopia (chemically induced, microbiology, physiopathology)
  • Edrophonium
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscle Fibers, Skeletal (microbiology)
  • Oculomotor Muscles (cytology, microbiology, physiopathology)
  • Ophthalmoplegia (chemically induced, microbiology, physiopathology)
  • Parasympathomimetics
  • Pursuit, Smooth (drug effects, physiology)
  • Saccades (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: